Nobody is more obstinate about technology than people who don’t know how to use it. What would you do if your Dad asked for your IT help, but then instantly made you regret it? One guy recently shared ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Feb 27 (Reuters) – Flagship-backed Generate Biomedicines’ shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Agent workflows make transport a first-order ...

An anonymous hacker group has reportedly breached the servers of a little-known Russian tech firm alleged to be involved in building the country’s unified military registration database. According to ...

I am a Backend Developer and Software Engineer with a solid background in Artificial Intelligence in academic and professional fields, looking forwa ...

The latest trends in software development from the Computer Weekly Application Developer Network. This is a guest post by Brian Sathianathan, chief technology officer and co-founder at Iterate.ai, ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Over the past few months, I have been helping developers and cloud professionals prepare for ...